Blue Jet Healthcare · NSE: BLUEJET · BSE: 544009
Q2 FY25 results · Jul–Sep 2024
Blue Jet Healthcare reported revenue from operations of ₹208.26 crore (up 14.8% from Q2 FY24) and net profit of ₹58.35 crore (up 21.9% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a standalone basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 208.26 | 181.35 | +14.8% | 162.90 | +27.8% |
| Other income | 12.07 | 8.21 | +47.0% | 8.71 | +38.5% |
| Total income | 220.33 | 189.57 | +16.2% | 171.61 | +28.4% |
| Profit before tax | 76.92 | 64.33 | +19.6% | 49.47 | +55.5% |
| Net profit for the period | 58.35 | 47.87 | +21.9% | 37.78 | +54.5% |
| EPS, basic (₹) | 3.36 | 2.76 | +21.9% | 2.18 | +54.3% |
| Net margin (%) | 28.0 | 26.4 | 23.2 |
Standalone
- Filed with BSE
- 29 Oct 2024, 15:19 IST
- Board meeting
- 29 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE